Regulation of nitric oxide production by salicylates and tenidap in human OA-affected cartilage, rat chondrosarcomas and bovine chondrocytes

Osteoarthritis and Cartilage

Volumn 6, Issue 4, 1998, Pages 269-277

  Attur, Mukundan G ^a   Patel, Rajesh ^a   DiCesare, Paul E ^a   Steiner, German C ^b   Abramson, Steven B ^c   Amin, Ashok R ^a,b  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c Hospital for Joint Diseases ^*

Author keywords

Nitric oxide; Non steroidal anti inflammatory drugs; Osteoarthritis; Prostaglandin

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; INDOMETACIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; SALICYLATE SODIUM; SALICYLIC ACID DERIVATIVE; TENIDAP;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CHONDROSARCOMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN TISSUE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 0032127060     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0120     Document Type: Article

References (46)

1. 1. Nathan C, Xie Q. Nitric oxide synthases: role, tolls, and controls. Cell 1994;78:915-18.
2. 2. Schmidt HHHW, Walter U. NO at work. Cell 1994;78:919-25.
3. 3. McCArtney-Francis N, Allen JB, Mizel DE, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;78:749-54.
4. 4. Stefanovic-Racic M, Stadler J, Evans CH. Nitric Oxide and Arthritis. Arthritis Rheum 1993;36:1036-44.
5. 5. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthase in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
6. 6. Amin AR, DiCesare P, Vyas P, Attur M, Tzeng E, Billiar TR. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for upregulated neuronal nitric oxide synthase. J Exp Med 1995;183:2087-02.
7. 7. Sakurai H, Kohsaka H, Liu M-F, Higashmiyama H, Hirata Y, Kanno K. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
8. 8. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 1997;40:261-9.
9. 9. Hauselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH. Differences in nitric oxide production by superficial and deep human articular chondrocytes: Implications for proteoglycan turnover in inflammatory joint diseases. J Immunol (in press).
10. 10. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Co12A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997;324:305-10.
11. 11. Frenkel SR, Clancy RM, Ricci JL, DiCesare PE, Rediske JJ, Abramson SB. Effects of nitric oxide on chondrocyte migration, adhesion, and cytoskeletal assembly. Arthritis Rheum 1996;39:1905-12.
12. 12. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1RA synthesis by human articular chondrocytes: possible role in osteoarthritis cartilage degradation. Osteoartritis and Cart 1996;4(1):77-84.
13. 13. Blanco FJ, Ochs RL, Schwartz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Amer J Pathology 1995;146(1):75-85.
14. 14. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
15. 15. Tamura T, Nakanishi T, Kimura Y, Takako H, Sasako T, Hiromichi N, Takahasi K, Takigawa M. Nitric oxide mediates interleukin-1 matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovasculasrization in arthritis. Endocrinology 1996;137:3729-37.
16. 16. Abramson S, Korchak H. Ludewig R, Edelson H, Haines K, Levin RI, et al. Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 1985;82(21):7227-31.
17. 17. Amin AR, Attur MG, Abramson SB. Regulation of nitric oxide in human osteoarthritis-affected cartilage: Implication for pharmacological intervention. In: Rubanyi GM, ed. The Pathophysiology & Clinical Application of Nitric Oxide. Harwood Academic Publishers (in press).
18. 18. Aydelotte MB, Kuettner KE. Differences between sub-populat/ions of cultured bovine articular chondrocytes. I. Morphology and catrilage matrix production. Conn Tissue Res 1988;18(3):205-22.
19. 19. Kuettner KE, Pauli BU, Gall G, Memoli VA, Schenk RK. Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and Morphology. J Cell Bio 1982;93(3):743-50.
20. 20. McCarthy MT, Toole BP. Membrane-associated hyaluronate-binding activity of chondrosarcoma chondrocytes. J Cell Phys 1989;141:191-202.
21. 21. Kenan S, Steiner GC. Experimental transplantation of the Swarm rat chondrosarcoma into bone: radiological and pathological studies. J Ortho Res 1991;8:781-92.
22. 22. Amin AR, Attur MG, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al. Superinduction of cyclooxygenase-2 in human osteoarthritis-affected cartilage: Influence of nitric oxide. J Clin Invest 1997;99:1231-77.
23. 23. Gilliam MB, Sherman MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrite using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 1993;212:359-65.
24. 24. Goldring S, Emery P, Young SP. Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line. J Immunol 1995;154:5384-90.
25. 25. Gilman AG, Rall TW, Nies AS, Taylor P. eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill. 1993.
26. 26. Di Cesare PE, Carlson CS, Attur M, Kale AA, Abramson SB, Amin AR. Up-regulation of inducible nitric oxide synthase and production of nitric oxide by the swarm rat chondrosarcoma. 1997. (Submitted for publication).
27. 27. Amin AR, Vyas P, Attur M, Leszezynska-Piziak J, Patel IR, Weissman G, et al. The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 1995;92:1926-30.
28. 28. Kleinert H, Euchenhofer C, Ihrig-Biedert I. Glucocorticoid inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa β. Mol Pharmacol 1996;49(1):14-21.
29. 29. Kunz D, Walker G, Eberhardt W, Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttransciptional regulation. Proc Natl Acad Sci USA 1996;93(1):255-9.
30. 30. Pittner RA, Spitzer JA. Steroid hormones inhibit induction of spontaneous nitric oxide production in cultured hepatocytes without changes in arginase activity or urea production. Proc Soc Exp Biol and Med 1993;202(4):499-504.
31. 31. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, et al. Cytokines, endotoxin, and glucocorticoid regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993;909(2):522-6.
32. 32. Abramson SB. Treatment of gout and crystal arthropathies and uses and mechanisms of action of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1992;4(3):295-300.
33. 33. Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT, et al. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Comm 1995;208:1053-9.
34. 34. Kepka-Lenhart D, Chen LC, Morris SM Jr. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line. J Leukoc Biol 1996;59(6): 840-6.
35. 35. Sakitani K, Kitade H, Inoue K, Kamiyam Y, Nishizawa M, Okumura T, et al. The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1 beta at a translational step, but not at a transcriptional step, in hepatocytes. Hepatology 1997;25(2):416-20.
36. 36. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res 1996;78:759-68.
37. 2, and IL-8. Proc Assoc Am Physicians 1998;110:1-8.
38. 38. Otterness IG, Bliven ML, Downs JT, Natoli EJ, Hanson DC. Inhibition of interleukin 1 synthesis by tenidap: a drug for arthritis. Cytokine 1991;3:277-83.
39. 39. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective Inhibition of cyclooxygenase (COX-2) reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-9.
40. 40. Robinson DR. Eicosanoids and related compounds. In: Koopman WJ, ed. Arthritis and Allied Conditions: A textbook of Rheumatology 13th Ed. pp. 515-28.
41. 41. Lorenz JJ, Furdon PJ, Taylor JD, Verghese MW, Chandra G, Rost TA, et al. A cyclic adenosine 3′, 5′-monophosphate signal is required for the induction of IL-1β by TNF-α in human monocytes. J Immunol 1995;155:836-44.
42. 42. Zhang Y, Dewitt DL, McNeely TB, Wahl SM, Wahl LM. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest 1997;99:894-900.
43. 43. Zahner G, Harendza S, Muller E, Wolf G, Thaiss F, Stahl RA. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesandgial cells. Kidney Int 1997;51:1116-23.
44. 44. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40.
45. 2 by nitric oxide in human OA-affected cartilage. (Manuscript in preparation).
46. 2 stimulates incorporation of proline into collagenase-digestible proteins in human articular chondrocytes: Identification of an effector autocrine loop involving insulin-like growth factor I. Mol Cell Endocrinol 1996;123: 27-35.